Medical Procedure News

RSS

Advent of HAART leads to decrease in mortality among people living with HIV/AIDS

During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.

2 Dec 2010

New analysis of stenting vs. endarterectomy for carotid occlusive disease

Doctors have long known that patients with carotid artery stenosis, narrowed blood vessels in the neck, are at significant risk for a stroke. The condition has severe implications. Annually, in the United States, 795,000 patients have strokes that often result in long-term disability or death. For years, however, researchers in North America and Europe have tried to determine the most effective method to treat narrowed or partially blocked carotid vessels.

2 Dec 2010

CSC files IND application to commence Phase I study for Spinal Muscular Atrophy

California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that CSC has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase I safety study on a jointly-developed stem cell-derived motor neuron transplantation therapy for Spinal Muscular Atrophy (SMA) Type I.

2 Dec 2010

Sleep HealthCenters enters agreement with U.S. HealthWorks to provide sleep medicine services

Sleep HealthCenters has entered into an agreement with U.S. HealthWorks to provide sleep medicine services as part of their occupational medicine programs.

2 Dec 2010

Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for long-term use in pediatric and adult type 1 Gaucher disease.

1 Dec 2010

Loyola's mortality rate from heart-bypass surgery 74% lower than at peer hospitals

Loyola University Hospital's mortality rate from heart-bypass surgery is 74 percent lower than the mortality rate at peer hospitals, according to Thomson Reuters Cardiovascular Benchmarks Report.

1 Dec 2010

GE Healthcare showcases low-dose CT innovations at 96th RSNA

For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.

1 Dec 2010

Study shows link between reduced hormone therapy and decline in breast cancer

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer. The researchers saw such a striking decrease, they believe they also have uncovered indirect evidence that hormones promote breast tumor growth.

1 Dec 2010

Los Angeles prosthodontist provides effective dental treatment for oral cancer patients

Oral cancer is a common condition affecting over 30,000 Americans each year. Worldwide the number falls into the hundreds of thousands, and a significant percentage of those with oral cancer end up losing teeth and normal mouth function in the absence of early cancer detection and treatment.

1 Dec 2010

Annual mammography screening reduces risk of mastectomy

Having a yearly mammogram greatly reduces the risk of mastectomy following breast cancer in women between the ages of 40 and 50, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2010

Roche NimbleGen announces NewGene as first certified service provider in the UK

Roche NimbleGen announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company.

1 Dec 2010

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Emerging Healthcare Solutions, Inc. announced today that its affiliate, Celulas Genetica, purchased a license to develop and market a revolutionary new medical treatment known as the Rutherford Procedure.

30 Nov 2010

Argos commences dosing in Arcelis personalized immunotherapy Phase 2b clinical trial for HIV

Argos Therapeutics today announced that it has initiated dosing of patients in a Phase 2b clinical trial of its Arcelis™ personalized immunotherapy for the treatment of HIV patients, AGS-004.

30 Nov 2010

Number of big babies rise along with obstetric complications

Doctors say that with more babies born oversized mostly to obese or overweight mothers the risks of shoulder injury and getting stuck during labour is on the rise. Horrifyingly sometimes obstetricians are resorting to breaking baby’s collarbones to facilitate delivery because their shoulders get stuck during childbirth. This is usually done in a potentially life-threatening is known as shoulder dystocia that compresses the umbilical cord or puts pressure on the neck, leaving the child starved of oxygen if not delivered immediately.

30 Nov 2010

Spinal Modulation's Dorsal Root Ganglion Stimulation Pilot Clinical Trial results to be presented at 14th NANS

SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its prospective, multicenter Dorsal Root Ganglion (DRG) Stimulation Clinical Trial will be presented by David Caraway, MD, PhD, Timothy Deer, MD and Robert Levy, MD, PhD at the 14th Annual North American Neuromodulation Society (NANS) meeting.

30 Nov 2010

Functional MRI reveals effectiveness of acupuncture in relieving pain

Using functional magnetic resonance imaging (fMRI), researchers have captured pictures of the brain while patients experienced a pain stimulus with and without acupuncture to determine acupuncture's effect on how the brain processes pain. Results of the study, which the researchers say suggest the effectiveness of acupuncture, were presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2010

Syneron launches CO2RE CO2 resurfacing system in US and Canada

Syneron Medical Ltd., the global leader in the medical aesthetic device marketplace, announced today the US Food and Drug Administration (FDA) and Health Canada clearance and commercial launch of its highly flexible CO2RE CO2 resurfacing system. CO2RE is a versatile fractional CO2 system that offers the unique ability to treat both superficial and deep skin layers simultaneously with precision-control over the intensity, pattern and depth of ablation.

30 Nov 2010

ABI therapy effective for treating microtears in hamstring injury: Study

Researchers in London say they have found an effective two-part treatment for microtears in the hamstring: injections of the patient's own blood and a steroid along with "dry-needling," in which repeated needle punctures cause controlled internal bleeding in the injured area. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

30 Nov 2010

Siemens to distribute Rcadia's COR Analyzer System

Rcadia Medical Imaging and Siemens Healthcare have entered into an agreement for Siemens to distribute Rcadia's COR Analyzer® System. The COR Analyzer's ability to identify stenotic lesions in Coronary Computed Tomography Angiography (cCTA) studies in combination with Siemens' Syngo®.via CT Cardio-Vascular Engine provides a comprehensive solution for evaluating suspected cardiac patients. The integration of both systems realizes a seamless workflow with enhanced productivity.

30 Nov 2010

Birmingham Institute performs non-invasive skin tightening procedure

With the increasing demand for non-surgical aesthetic procedures, the FDA's recent clearance of an ultrasound device to tighten sagging skin has come as great news to consumers, especially those in Southeast Michigan, home to one of the first of these Ulthera Systems in the nation.

29 Nov 2010